ZL-1310 earns fast track designation in extensive-stage small cell lung cancer after early trial data showed tumor shrinkage in most patients treated. The United States Food and Drug Administration ...

Small-cell lung cancer is a highly malignant form of lung cancer, also known as oat-cell carcinoma, that accounts for approximately 15% of lung cancer cases. Composed of small, ovoid cells with ...

I am responsible for the creativity, education, operating system, productivity, and small business categories, among others. I also worked for several years on the consumer electronics team ...

A storage bench, which is just as beautiful as it is practical. If you're tired of blankets piling up in bedside chairs — not ...

Perspective from Charu Aggarwal, MD, MPH, FASCO CHICAGO — A 14-gene molecular assay could help predict which patients with early-stage non-small cell lung cancer will benefit from adjuvant ...

No PG Business Card Master List - Best Credit Cards NO Doc, 0% APR Cards for New LLCs - Amex Gold (60k bonus pts) - Free Stuff! ($0.00) See every credit card you're pre-approved for with just a ...

Roche’s plan to bolster Tecentriq’s position in small cell lung cancer with Jazz Pharmaceuticals’ Zepzelca has paid off. But the pair’s success leaves room for improvement for future ...

A new drug developed by a mainland Chinese biotechnology company is effective in combating three types of cancer that currently have limited treatment options, according to a multinational study ...

The Company is on track to initiate a pivotal study for ZL-1310 in small cell lung cancer (SCLC) in 2025 SHANGHAI & CAMBRIDGE, Mass., May 19, 2025--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ ...